Search
Search
Illumina
Instrument
- Data passing through the filter: the number of clusters passing through the filter ranges from 8-25 million - Capacity per run: ranges from 2.5 GB - 7.5 GB data output - Data Quality (Quality Score) > Q30 (accuracy 99.9%)
Model: MiniSeq
Manufacturer: Illumina/USA
– New generation DNA sequencing system using synthetic sequencing technology: Sequencing by Synthesis – SBS
– Next Generation Sequencing, allowing to run the entire DNA and RNA amplification process combined with sequencing analysis on a single system
– Maximum reading capacity: 7.5 Gb (equivalent to 7.5 billion bases) within 24 hours
– Data Quality (Quality Score) > Q30 (accuracy 99.9%)
– Whole-genome sequencing for small genomes (Small Whole-genome Resequencing)
– Targeted sequencing
– Sequencing to detect gene mutations related to colorectal cancer, lung cancer, … application in early screening and targeted treatment
– Sequencing mRNA, small RNA, micro RNA
– Paired-end sequencing of target amplicons
– Paired-end gene sequencing for target gene expression profiling
– Sequencing time when using the High-Output Reagent Kit
• Sequencing 1 x 50 bp in 7 hours (384 samples)
• Sequencing 2 x 75 bp in 13 h (23 samples)
• 24h 2 x 150 bp sequencing (50 small genome sequencing samples, 28 target amplicon sequencing samples)
Compatible with 2 types of flow cells with different capacities (large capacity and medium capacity), depending on the purpose of sequencing
– Data passing through the filter: the number of clusters passing through the filter ranges from 8-25 million
– Capacity per run: ranges from 2.5 GB – 7.5 GB data output
– Data Quality (Quality Score) > Q30 (accuracy 99.9%). Percentage of data with quality > 85% > Q30 (1-way solves 25 million readings, 2-way gets 50 million reads)
– Optical system using excitation LEDs (515 nm, 650 nm)
Fully automated process: 10 min of manual operation and 6 h of sequencing (1 x 36 bp) including clustering, sequencing, and automatic washing after run
– Has radio wave consumables (RFID – tracking) feature, using pre-loaded chemical cartridges
Running capacity: up to 384 samples can be analyzed in one sequencing
Supplier: Illumina
The EntroGen NGS Targeted Hotspot Panel is a comprehensive assay that detects clinically relevant mutations in solid tumors using next-generation sequencing, compatible with fresh frozen and FFPE samples. It offers high sensitivity, low DNA input, and the ability to batch up to 12 samples in a single run, making it ideal for labs with limited sample volumes.
EntroGen’s BRCA Complete™ Expanded Panel is a comprehensive NGS solution that detects both germline and somatic mutations in genes like BRCA1, BRCA2, CHEK2, PALB2, RAD51C, and TP53 with high sensitivity and specificity. Compatible with blood, fresh frozen, and FFPE samples, the panel reduces allele dropouts and off-target reads using a tiled amplicon PCR approach. It includes reagents for library preparation and user-friendly software for easy mutation identification, along with quality control assays to ensure high-quality data without repeat sequencing.
SOLIDaccuTest™ is an excellent tool for discovering variants associated with solid tumors using a comprehensive approach to next-generation sequencing (NGS). It reflects the latest research trends and is optimized for medical purposes by selecting essential genes of solid tumors including lung, colon, breast, skin brain, stomach and ovarian cancers, etc.
BRCAaccuTest™ PLUS with CE-IVD certificate for HBOC Breast/Ovarian Cancer Test
BRCAaccuTest™ & BRCAaccuTest™PLUS is a regent for producing libraries for
analyzing the BRCA ½ genes using the NGS (next-generation sequencing) method,
which analyzes genomic DNA derived from blood or FFPE tissues.
Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time
Model: NextSeq 1000
Manufacturer: Illumina
Origin: Singapore/United States
Launching year: 01/2020
The PANA RealTyper™ HPV Screening Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC
PANA RealTyperTM HPV Kit is a CE marked diagnostic device in accordance with the European Union in vitro Diagnostic Medical Device Directive 98/79/EC.
Model: NovaSeq 6000
Manufacturer: Illumina/USA
– Scalable platform
Match data output, time to results, and price per sample to study needs
– Flexible performance
Configure sequencing method, flow cell type, and read length to support a broad range of applications
– Streamlined operation
Increase lab efficiency with a simplified workflow and reduced hands-on time
Assisted Reproductive 
Prenatal screening 
New-born screening 
Screening 
Diagnosis 
Early detection 
Monitoring 
Illumina infectious diseases testing group 
GeneProof infectious diseases testing group 
Panagene infectious diseases testing group 
Digital forensics 
Inspection of Ballistics and Mechanical Traces 
Document examination 
Crime scene examination 
